Burcon Receives Three Patent Grants from the USPTO
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) has been granted three new patents by the United States Patent and Trademark Office (USPTO). Two patents cover the production process and consumer applications for Peazazz pea protein, while one patent is for the production process of their soy protein.
The specific patents granted are U.S. patents 12,102,100 and 12,108,774 for pea protein, and U.S. patent 12,089,614 for soy protein. These additions expand Burcon's intellectual property portfolio to over 100 issued patents globally, including 61 U.S. patents, with more than 80 pending patent applications (12 in the U.S.).
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) ha ricevuto tre nuovi brevetti dall'Ufficio Brevetti e Marchi degli Stati Uniti (USPTO). Due brevetti riguardano il processo di produzione e le applicazioni per i consumatori della proteina di piselli Peazazz, mentre un brevetto è relativo al processo di produzione della proteina di soia.
I brevetti specifici concessi sono i brevetti statunitensi 12.102.100 e 12.108.774 per la proteina di piselli, e il brevetto statunitense 12.089.614 per la proteina di soia. Queste aggiunte ampliano il portafoglio di proprietà intellettuale di Burcon a oltre 100 brevetti rilasciati globalmente, inclusi 61 brevetti statunitensi, con più di 80 domande di brevetto in attesa (12 negli Stati Uniti).
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) ha recibido tres nuevas patentes por parte de la Oficina de Patentes y Marcas de Estados Unidos (USPTO). Dos patentes cubren el proceso de producción y las aplicaciones para consumidores de proteína de guisante Peazazz, mientras que una patente es para el proceso de producción de proteína de soya.
Las patentes específicas otorgadas son las patentes estadounidenses 12.102.100 y 12.108.774 para la proteína de guisante, y la patente estadounidense 12.089.614 para la proteína de soya. Estas adiciones amplían el portafolio de propiedad intelectual de Burcon a más de 100 patentes emitidas a nivel global, incluyendo 61 patentes estadounidenses, con más de 80 solicitudes de patente pendientes (12 en EE.UU.).
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF)가 미국 특허청(USPTO)으로부터 세 개의 새로운 특허를 받았습니다. 두 개의 특허는 Peazazz 완두콩 단백질의 생산 과정과 소비자 용도를 다루고 있으며, 하나의 특허는 콩 단백질의 생산 과정에 관한 것입니다.
부여된 구체적인 특허는 완두콩 단백질에 대한 미국 특허 12,102,100 및 12,108,774, 그리고 콩 단백질에 대한 미국 특허 12,089,614입니다. 이러한 추가로 인해 Burcon의 지적 재산 포트폴리오는 전 세계에 걸쳐 100개 이상의 발급된 특허로 확장되며, 여기에는 61개의 미국 특허와 80개 이상의 대기 중인 특허 출원이 포함됩니다(미국에서 12개).
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) a reçu trois nouveaux brevets de l'Office des brevets et des marques des États-Unis (USPTO). Deux brevets concernent le processus de production et les applications pour les consommateurs de protéine de pois Peazazz, tandis qu'un brevet concerne le processus de production de protéine de soja.
Les brevets spécifiques accordés sont les brevets américains 12.102.100 et 12.108.774 pour la protéine de pois, et le brevet américain 12.089.614 pour la protéine de soja. Ces ajouts élargissent le portefeuille de propriété intellectuelle de Burcon à plus de 100 brevets délivrés dans le monde, y compris 61 brevets américains, avec plus de 80 demandes de brevets en attente (12 aux États-Unis).
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) hat vom United States Patent and Trademark Office (USPTO) drei neue Patente erhalten. Zwei Patente betreffen den Produktionsprozess und die Verbraucheranwendungen für Peazazz Erbsenprotein, während ein Patent den Produktionsprozess für Sojaprotein abdeckt.
Die spezifischen erteilten Patente sind die US-Patente 12.102.100 und 12.108.774 für Erbsenprotein sowie das US-Patent 12.089.614 für Sojaprotein. Diese Ergänzungen erweitern Burcons Portfolio an geistigem Eigentum auf über 100 erteilte Patente weltweit, einschließlich 61 US-Patente, mit über 80 anhängigen Patentanmeldungen (12 in den USA).
- Strengthened intellectual property protection for key products
- Expanded patent portfolio with three new U.S. patents
- Strategic timing aligned with upcoming product launch
- None.
Vancouver, British Columbia--(Newsfile Corp. - December 10, 2024) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce that it has been issued three patents from the United States Patent and Trademark Office ("USPTO"), two of which are for patent applications covering the production process and consumer applications for Burcon's Peazazz® pea protein, and one for a patent application covering the production process of Burcon's soy protein.
"We are pleased to further enhance our strong intellectual property portfolio," said Kip Underwood, Burcon's chief executive officer. "Protecting our competitive edge in key markets is a top priority as we prepare to introduce our full range of premium protein ingredients. These recent patent grants, particularly for our pea protein, support the launch of our next-generation pea protein isolate, which we anticipate will quickly gain traction in the market."
U.S. patents 12,102,100 and 12,108,774 cover the unique processes to produce Burcon's high purity Peazazz pea protein isolate and its use in consumer food and beverage applications. U.S. patent 12,089,614 covers the unique process to produce Burcon's high purity soy protein isolate. These patent grants add to Burcon's existing patent portfolio of over 100 issued patents in various countries, including 61 issued U.S. patents, and more than 80 additional pending patent applications, 12 of which are U.S. patent applications.
About Burcon NutraScience Corporation
Burcon is a global technology leader in the development of plant-based proteins for foods and beverages. Our proteins exhibit superior functionality, taste and nutrition, making them ideal ingredients for food formulators. With over two decades of experience, Burcon has amassed an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. Burcon is committed to delivering next-generation, best-in-class protein solutions, positioning itself as a key player in the rapidly expanding plant-based market. Supporting the growing trend towards a plant-based diet, Burcon offers sustainable protein ingredients that we believe are better for you and better for the planet. For more information, visit www.burcon.ca.
Forward-Looking Information Cautionary Statement
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations; and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2024 and its other public filings with Canadian securities regulators on SEDAR+ at www.sedarplus.ca. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.
Industry and Investor Contact:
Paul Lam
Director, Investor Relations and Communications
Burcon NutraScience Corporation
Tel (604) 733-0896, Toll-free (888) 408-7960
plam@burcon.ca www.burcon.ca
Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267
TECH@CCOM-PR.COM
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/233139
FAQ
What new patents did Burcon (BRCNF) receive from the USPTO in December 2024?
How many total patents does Burcon (BRCNF) currently hold?
What products are covered by Burcon's (BRCNF) new USPTO patents?
